• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
GenPhar, Inc. - Product Pipeline Review - Q2 2011 Product Image

GenPhar, Inc. - Product Pipeline Review - Q2 2011

  • ID: 1845416
  • July 2011
  • 19 pages
  • Global Markets Direct

GenPhar, Inc. – Product Pipeline Review – Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, “GenPhar, Inc. - Product Pipeline Review - Q2 2011” provides data on the GenPhar, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, GenPhar, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from GenPhar, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- GenPhar, Inc. - Brief GenPhar, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of GenPhar, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, READ MORE >



List of Tables
List of Figures
GenPhar, Inc. Snapshot
GenPhar, Inc. Overview
Key Information
Key Facts
GenPhar, Inc. – Research and Development Overview
Key Therapeutic Areas
GenPhar, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
GenPhar, Inc. – Pipeline Products Glance
GenPhar, Inc. Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
GenPhar, Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
GenPhar, Inc. – Drug Profiles
Pan-filovirus Vaccine
Product Description
Mechanism of Action
R&D Progress
TheraVax Based Hepatitis B Vaccine
Product Description
Mechanism of Action
R&D Progress
Dengue Virus Vaccine
Product Description
Mechanism of Action
R&D Progress
Drug For Dengue Virus
Product Description
Mechanism of Action
R&D Progress
Pan-fluvirus Vaccine
Product Description
Mechanism of Action
R&D Progress
GenPhar, Inc. – Pipeline Analysis
GenPhar, Inc. – Pipeline Products by Therapeutic Class
GenPhar, Inc. – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
GenPhar, Inc. – Pipeline by Therapy Area and Indication, 2011
GenPhar, Inc. – Pipeline by Stage of Development, 2011
GenPhar, Inc. – Monotherapy Products in Pipeline, 2011
GenPhar, Inc. - Phase I, 2011
GenPhar, Inc. - Pipeline By Therapeutic Class, 2011

List of Figures
GenPhar, Inc. – Pipeline by Therapy Area and Indication, 2011
GenPhar, Inc. – Pipeline by Stage of Development, 2011
GenPhar, Inc. – Monotherapy Products in Pipeline, 2011
GenPhar, Inc. – Pipeline By Therapeutic Class, 2011

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos